424 related articles for article (PubMed ID: 31817935)
1. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
2. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.
Kehrloesser S; Osterburg C; Tuppi M; Schäfer B; Vousden KH; Dötsch V
Cell Death Differ; 2016 Dec; 23(12):1952-1960. PubMed ID: 27447112
[TBL] [Abstract][Full Text] [Related]
4. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
5. Functional interplay between MDM2, p63/p73 and mutant p53.
Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
[TBL] [Abstract][Full Text] [Related]
6. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
7. p53 Family isoforms.
Bourdon JC
Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
[TBL] [Abstract][Full Text] [Related]
8. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
[TBL] [Abstract][Full Text] [Related]
9. Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry.
Guven-Maiorov E; Sakakibara N; Ponnamperuma RM; Dong K; Matar H; King KE; Weinberg WC
Mol Carcinog; 2022 Jul; 61(7):629-642. PubMed ID: 35560453
[TBL] [Abstract][Full Text] [Related]
10. Emerging Roles of p53 Family Members in Glucose Metabolism.
Itahana Y; Itahana K
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.
Zhang J; Sun W; Kong X; Zhang Y; Yang HJ; Ren C; Jiang Y; Chen M; Chen X
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24259-24267. PubMed ID: 31712410
[TBL] [Abstract][Full Text] [Related]
12. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li Y; Prives C
Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431
[TBL] [Abstract][Full Text] [Related]
13. Structural diversity of p63 and p73 isoforms.
Osterburg C; Dötsch V
Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
15. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
16. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
17. NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner.
Cai BH; Bai ZY; Lien CF; Yu SJ; Lu RY; Wu MH; Wu WC; Chen CC; Hsu YC
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327630
[TBL] [Abstract][Full Text] [Related]
18. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
19. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific expression of p73 and p63 isoforms in human tissues.
Marshall CB; Beeler JS; Lehmann BD; Gonzalez-Ericsson P; Sanchez V; Sanders ME; Boyd KL; Pietenpol JA
Cell Death Dis; 2021 Jul; 12(8):745. PubMed ID: 34315849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
